EPIX Pharmaceuticals appoints interim CEO
This article was originally published in Scrip
Executive Summary
EPIX Pharmaceuticals (US), a biopharmaceutical company discovering and developing therapeutics through the use of its in silico drug discovery platform, has appointed Dr Elkan Gamzu interim chief executive officer, following the resignation of Dr Michael Kauffman as CEO and a director. Dr Gamzu is currently a consultant to the biotechnology and pharmaceutical industries and has held a number of senior executive positions in them.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.